Eliana Merle's Stock Ratings

UBS Analyst

Eliana Merle is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

-0.71%

Smart Score

47.6%

Overall Average Return Percentile

36th

Number of Ratings

39
Buy NowGet Alert
06/28/2024ALNYBuy Now
Alnylam Pharmaceuticals
$255.1112.89%$253 → $288MaintainsBuyGet Alert
06/20/2024ZNTLBuy Now
Zentalis Pharma
$4.2019.05%$28 → $5DowngradeBuy → NeutralGet Alert
05/28/2024BBIOBuy Now
BridgeBio Pharma
$26.1479.8%$51 → $47MaintainsBuyGet Alert
05/08/2024APLSBuy Now
Apellis Pharmaceuticals
$37.11129.05%$89 → $85MaintainsBuyGet Alert
05/07/2024MRNABuy Now
Moderna
$116.5029.61%$143 → $151MaintainsBuyGet Alert
04/04/2024KODBuy Now
Kodiak Sciences
$2.46103.25%$3 → $5MaintainsNeutralGet Alert
03/27/2024TERNBuy Now
Terns Pharma
$7.53139.04%$19 → $18MaintainsBuyGet Alert
03/27/2024BNTXBuy Now
BioNTech
$80.4925.48%$110 → $101MaintainsNeutralGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$290.7441.02%$337 → $410MaintainsBuyGet Alert
03/05/2024AKROBuy Now
Akero Therapeutics
$22.1989.27%$39 → $42MaintainsBuyGet Alert
03/04/2024APLSBuy Now
Apellis Pharmaceuticals
$37.11139.83%$87 → $89MaintainsBuyGet Alert
02/22/2024RAPTBuy Now
RAPT Therapeutics
$3.07225.73%$61 → $10DowngradeBuy → NeutralGet Alert
02/14/2024CBAYBuy Now
CymaBay Therapeutics
——$25 → $32.5DowngradeBuy → NeutralGet Alert
12/21/2023KODBuy Now
Kodiak Sciences
$2.4621.95%$4 → $3MaintainsNeutralGet Alert
12/20/2023RVMDBuy Now
Revolution Medicines
$42.30-5.44% → $40Initiates → BuyGet Alert
11/02/2023ANABBuy Now
AnaptysBio
$25.47-17.55%$28 → $21MaintainsNeutralGet Alert
10/12/2023ETNBBuy Now
89bio
$7.90216.46%$36 → $25MaintainsBuyGet Alert
10/12/2023AKROBuy Now
Akero Therapeutics
$22.1975.75%$83 → $39MaintainsBuyGet Alert
09/26/2023CBAYBuy Now
CymaBay Therapeutics
——$18 → $25MaintainsBuyGet Alert
08/28/2023ETNBBuy Now
89bio
$7.90355.7% → $36Initiates → BuyGet Alert
08/28/2023AKROBuy Now
Akero Therapeutics
$22.19274.04% → $83Initiates → BuyGet Alert
08/23/2023APLSBuy Now
Apellis Pharmaceuticals
$37.1172.46%$60 → $64MaintainsBuyGet Alert
08/14/2023CBAYBuy Now
CymaBay Therapeutics
—— → $18Initiates → BuyGet Alert
07/27/2023KODBuy Now
Kodiak Sciences
$2.4662.6%$15 → $4DowngradeBuy → NeutralGet Alert
06/26/2023MRNABuy Now
Moderna
$116.5063.95%$221 → $191UpgradeNeutral → BuyGet Alert
05/19/2023QUREBuy Now
uniQure
$3.781011.11%$45 → $42MaintainsBuyGet Alert
05/03/2023ISEEBuy Now
IVERIC bio
——$34 → $40DowngradeBuy → NeutralGet Alert
03/31/2023BNTXBuy Now
BioNTech
$80.4990.09%$168 → $153MaintainsNeutralGet Alert
02/07/2023TERNBuy Now
Terns Pharma
$7.53152.32% → $19Initiates → BuyGet Alert
01/19/2023CVACBuy Now
CureVac
$3.12476.92% → $18UpgradeNeutral → BuyGet Alert
12/21/2022MDGLBuy Now
Madrigal Pharmaceuticals
$290.7415.91%$161 → $337MaintainsBuyGet Alert
12/07/2022GOSSBuy Now
Gossamer Bio
$1.15595.65%$19 → $8MaintainsBuyGet Alert
11/23/2022QUREBuy Now
uniQure
$3.781011.11%$40 → $42MaintainsBuyGet Alert
10/13/2022GLUEBuy Now
Monte Rosa Therapeutics
$3.77483.55% → $22Initiates → BuyGet Alert
08/02/2022ISEEBuy Now
IVERIC bio
—— → $20Initiates → BuyGet Alert
06/23/2022RGNXBuy Now
Regenxbio
$10.63342.14%$51 → $47MaintainsBuyGet Alert
04/06/2022GOSSBuy Now
Gossamer Bio
$1.151552.17% → $19Initiates → BuyGet Alert
03/17/2022QUREBuy Now
uniQure
$3.78958.2% → $40UpgradeNeutral → BuyGet Alert
01/21/2022MRNABuy Now
Moderna
$116.5089.7% → $221Initiates → NeutralGet Alert